Observational studyAnnals of African medicine2025
Diagnostic Accuracy of Adenosine Deaminase Levels in Peripheral Blood Lymphocyte of Patients with Pulmonary Tuberculosis.
Observational study in Annals of African medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
contextTuberculosis (TB) is a well-known global health problem with one-fifth of the global burden in India. Although there are diagnostic and prognostic markers for TB, there is lack of specificity and sensitivity of diagnostic methods.
aimsThe goal of this study was to assess the diagnostic value of blood lymphocyte adenosine deaminase (ADA) levels in pulmonary TB patients. SUBJECTS AND
methodsThis was a prospective observational case-control study. A total of 80 subjects were included in this study and were divided into two groups: 40 people who were healthy in every respect and 40 patients with pulmonary TB. ADA activity was measured in each group by the Giusti and Galanti method using a commercial kit. STATISTICAL ANALYSIS USED: Data were analyzed using t -test with receiver operating characteristic curve analysis done to identify the cutoff values for ADA that had maximum sensitivity and specificity.
resultsThe mean serum ADA level in the pulmonary TB group was significantly increased as compared to control group ( P < 0.0001), whereas blood lymphocyte ADA levels as well as blood lymphocyte/serum ADA ratio in the pulmonary TB group were significantly decreased as compared control group ( P < 0.0001). In regard to the cutoff value of <34.06 IU/mg protein in patients with pulmonary TB, sensitivity and specificity were 90.00% and 80.00%, respectively.
conclusionsBlood lymphocyte ADA level may be used as a biomarker for the diagnosis of pulmonary TB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.